BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8242596)

  • 1. Translocation (2;4)(p23;q25): an additional case of a new recurrent anomaly in acute myeloid leukemia.
    Shi G; Weh HJ; Hossfeld DK
    Cancer Genet Cytogenet; 1993 Oct; 70(2):140-1. PubMed ID: 8242596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel translocation (2;4) with consistent involvement of 2p23 in acute nonlymphocytic leukemia (M2).
    Farag S; Challis J; White J; Garson OM
    Cancer Genet Cytogenet; 1992 Jan; 58(1):48-51. PubMed ID: 1728949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translocation (12;15)(p13;q13) in a patient with relapsed acute myeloid leukemia.
    Lim SW; Falk RE; Look RM; Fuerst MM; Lawrence GN; Kusuanco DA; Giles FJ
    Cancer Genet Cytogenet; 1996 Feb; 86(2):165-7. PubMed ID: 8603347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translocation (9;17) a novel translocation in acute myeloid leukaemia.
    Brown SA; Czepulkowski B; Ireland R
    Leuk Res; 1996; 20(11-12):987-8. PubMed ID: 9009258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The detection of minimal residual disease by DEK/CAN chimeric m-RNA in a case of AML M2 with translocation t(6;9) (p23;q34) after chemotherapy and peripheral blood stem cell transplantation].
    Toyosawa M; Shinohara K; Ariyoshi K; Ando T; Kobayashi M; Hikiji K
    Rinsho Ketsueki; 1997 Jan; 38(1):33-40. PubMed ID: 9028159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marked bone marrow eosinophilia at the time of relapse of acute myeloblastic leukaemia in association with the appearance of translocation t(12;20)(q24;q11).
    Partridge F; Richardson W; Kearns P; Wilcox R; Majumdar G
    Leuk Lymphoma; 1996 Jun; 22(1-2):181-2. PubMed ID: 8724547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two additional cases of acute myeloid leukemia with t(7;11)(p15;p15) having low neutrophil alkaline phosphatase scores.
    Fujimura T; Ohyashiki K; Ohyashiki JH; Kawakubo K; Iwabuchi A; Kodama A; Toyama K
    Cancer Genet Cytogenet; 1993 Jul; 68(2):143-6. PubMed ID: 8353806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute myelogenous leukemia associated with Ollier disease.
    White MS; Martin PL; McLean TW
    Pediatr Blood Cancer; 2008 Mar; 50(3):645-6. PubMed ID: 16991136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo acute myelogenous leukemia with trilineage myelodysplasia associated with t(8;21)(q22;q22).
    Fujisawa S; Togawa J; Tanaka M; Koharazawa H; Aoba M; Fujita H; Murata T; Kanamori H; Matsuzaki M; Mohri H; Ishigatsubo Y
    Intern Med; 1999 Jul; 38(7):607-11. PubMed ID: 10435370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complex chromosome 8;21 translocation with associated hyperdiploidy in acute myeloid leukemia (FAB-M2).
    Corral Mdel P; Villa O; Alfaro EM; Alonso CN; Baro C; Felice MS; Rossi J; Solé F; Gallego MS
    Pediatr Blood Cancer; 2008 Mar; 50(3):651-4. PubMed ID: 17405156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired acute myelogenous leukemia after therapy for acute promyelocytic leukemia with t(15;17): a case report and review of the literature.
    Betancourt-García RD; Castro J; Fernández AC; López-Enríquez A; Fradera J; Pacheco E
    P R Health Sci J; 2009 Jun; 28(2):146-50. PubMed ID: 19530558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A third case of apparent t(2;4)(p23;q25) represents ins(2;4) with deletion of 2p.
    Richkind KE; Lamb A; Lytle C; Velasco J
    Leukemia; 1996 Nov; 10(11):1847. PubMed ID: 8892694
    [No Abstract]   [Full Text] [Related]  

  • 13. High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial.
    Willemze R; Suciu S; Meloni G; Labar B; Marie JP; Halkes CJ; Muus P; Mistrik M; Amadori S; Specchia G; Fabbiano F; Nobile F; Sborgia M; Camera A; Selleslag DL; Lefrère F; Magro D; Sica S; Cantore N; Beksac M; Berneman Z; Thomas X; Melillo L; Guimaraes JE; Leoni P; Luppi M; Mitra ME; Bron D; Fillet G; Marijt EW; Venditti A; Hagemeijer A; Mancini M; Jansen J; Cilloni D; Meert L; Fazi P; Vignetti M; Trisolini SM; Mandelli F; de Witte T
    J Clin Oncol; 2014 Jan; 32(3):219-28. PubMed ID: 24297940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trisomy 21 with t(5; 11) chromosomal translocation as new unfavorable cytogenetic abnormalities in pediatric acute myeloid leukemia type M2: One case report of nine-year follow-up and literature review.
    Wang L; Wu XY; Jin RM; Zhang BY; Qiu YN
    J Huazhong Univ Sci Technolog Med Sci; 2017 Oct; 37(5):807-810. PubMed ID: 29058300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant t(4;11) and t(1;19) in a patient with biphenotypic acute leukemia.
    Gozzetti A; Calabrese S; Raspadori D; Crupi R; Tassi M; Bocchia M; Fabbri A; Lauria F
    Cancer Genet Cytogenet; 2007 Aug; 177(1):81-2. PubMed ID: 17693199
    [No Abstract]   [Full Text] [Related]  

  • 16. Complex t(2;21;8)(p12;q22;q22): a variant t(8;21) in a patient with acute myeloid leukemia (AML-M2).
    Wang H; Yang W; Shao H; Zhang J; Qi L; Liao A; Li Y; Liu Z
    Cancer Genet Cytogenet; 2009 Jan; 188(2):95-8. PubMed ID: 19100512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unexpected pancytopenia following treatment of acute lymphoblastic leukemia.
    Innes A; May PC; Pavlů J; Bain BJ
    Am J Hematol; 2012 Apr; 87(4):412. PubMed ID: 21953481
    [No Abstract]   [Full Text] [Related]  

  • 18. Jumping translocation involving 1q21 during long-term complete remission of acute myeloid leukemia.
    Nagai S; Nannya Y; Takahashi T; Kurokawa M
    Ann Hematol; 2010 Jul; 89(7):741-2. PubMed ID: 19904535
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical Impact of Additional Cytogenetic Aberrations, cKIT and RAS Mutations, and Treatment Elements in Pediatric t(8;21)-AML: Results From an International Retrospective Study by the International Berlin-Frankfurt-Münster Study Group.
    Klein K; Kaspers G; Harrison CJ; Beverloo HB; Reedijk A; Bongers M; Cloos J; Pession A; Reinhardt D; Zimmerman M; Creutzig U; Dworzak M; Alonzo T; Johnston D; Hirsch B; Zapotocky M; De Moerloose B; Fynn A; Lee V; Taga T; Tawa A; Auvrignon A; Zeller B; Forestier E; Salgado C; Balwierz W; Popa A; Rubnitz J; Raimondi S; Gibson B
    J Clin Oncol; 2015 Dec; 33(36):4247-58. PubMed ID: 26573082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unfavourable outcome of a patient with M2 acute non lymphocytic leukemia and a 47,XY,t(5;7)(q34;q21), +8 karyotype.
    Testoni N; Zaccaria A; Celso B; Tura S
    Haematologica; 1991; 76(1):65-8. PubMed ID: 2055562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.